Sanofi-Aventis Renews License for Genomatix Microarray Software | GenomeWeb
NEW YORK (GenomeWeb News) - Genomatix said yesterday that Sanofi-Aventis has renewed its multi-site license for its Microarray Analysis Pipeline software.
 
The software analyzes data for a number of micorarray applications, including gene expression, tiling microarrays, and ChIP-on-chip studies.
 
Sanofi-Aventis originally licensed the company’s GenomatixSuite software in 2005.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.